Comparison of low dose magnesium sulphate regime with standard Pritchard regime in severe preeclampsia and eclampsia: a tertiary centre experience

Authors

  • Indu Gaur Department of Obstetrics and Gynecology, Military Hospital, Meerut, Uttar Pradesh, India
  • Kanishka Kumar Department of Obstetrics and Gynecology, Military Hospital, Meerut, Uttar Pradesh, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20220889

Keywords:

Eclampsia, Pre-eclampsia, Magnesium sulphate, Convulsions, Pritchard regimen

Abstract

Background: We tried to see if omitting the intravenous (IV) loading dose of magnesium sulphate (MgSo4) would result in similar outcome in comparison to the standard loading dose (intravenous+intramuscular) in eclampsia in preventing convulsions.

Methods: Patients were randomized into 2 groups. In group A (modified Pritchard regimen), IV loading dose of MgSo4 was omitted (only IM loading dose was given) and maintenance dose was given for 12 hours. In group B, standard Pritchard regimen was followed, both IV and IM given as loading dose and maintenance dose was given for 24 hours. Our aim was to see if modified Pritchard regimen was as effective as the standard Pritchard regimen.

Results: There was no difference in age, parity, gestational age at presentation, mode of child birth between both regimens. After 1 hour of loading dose, in both pre-eclampsia (PE) and eclampsia patients, in both groups A and B, therapeutic range of MgSo4 was reached with added benefit of less propensity of toxicity in group A (as IV dose was omitted). Out of 64 women with eclampsia, recurrent convulsions were seen in 6 women (20.68%) of group A and 11 women (31.4%) of group B (p=0.333). None of the women of severe PE had convulsion after loading dose of MgSO4 in either of the two groups.

Conclusions: We conclude that efficacy of reduced loading dose regimen (omitting IV loading dose) and 12 hour maintenance dose of MgSo4 is similar to standard Pritchard regimen (which employs full loading dose and 24 hour maintenance dose) in both prophylaxis of convulsion in severe preeclampsia and controlling convulsion and preventing recurrent convulsion in eclampsia with the obvious lower propensity for MgSo4 toxicity.

Author Biography

Indu Gaur, Department of Obstetrics and Gynecology, Military Hospital, Meerut, Uttar Pradesh, India

Major 

Assistant Professor

Department of Obstetrics and Gynaecology

References

Tukur J. The use of magnesium sulphate for the treatment of severe pre-eclampsia and eclampsia. Ann Afr Med. 2009;8(2).

Firoz T, Sanghvi H, Merialdi M, vonDadelszen P. Pre-eclampsia in low and middle income countries. Best Pract Res Clin Obstetr Gynaecol. 2011;25(4):537-48.

Bigdeli M, Zafar S, Assad H, Ghaffar A. Health system barriers to access and use of magnesium sulfate for women with severe pre-eclampsia and eclampsia in Pakistan: evidence for policy and practice. PloS One. 2013;8(3):59158.

Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Williams Obstetrics. 24th ed. McGraw-Hill; 2014: 728.

Aabidha PM, Cherian AG, Paul E, Helan J. Maternal and fetal outcome in pre-eclampsia in a secondary care hospital in South India. J Fam Med Prim Care. 2015;4(2):257.

Group TE. Which anticonvulsant for women with eclampsia? Evidence from the collaborative eclampsia trial. Lancet. 1995;345(8963):1455-63.

Omu AE, Al-Harmi J, Vedi HL, Mlechkova L, Sayed AF, Al-Ragum NS. Magnesium sulphate therapy in women with pre-eclampsia and eclampsia in Kuwait. Med Prin Pract. 2008;17(3):227-32.

Trial CE. Which anticonvulsant for women with eclampsia. Lancet. 1995;10(345):8963.

Phuapradit W, Saropala N, Haruvasin S, Thuvasethakul P. Serum level of magnesium attained in magnesium sulfate therapy for severe preeclampsia. J Obstetr Gynaecol Res. 1993;19(4):387-90.

Witlin AG. Prevention and treatment of eclamptic convulsions. Clin Obstetr Gynecol. 1999;42(3):507.

Cunningham F, Leveno K, Bloom S, Spong CY, Dashe J. Williams Obstetrics. 24th ed. McGraw-Hill; 2014: 759.

Savitha TS, Suvarna R, Uma T. A comparative study of low dose magnesium sulphate regime versus zuspan’s regime in severe pre-eclampsia and eclampsia. J Evolut Med Dent Sci. 2015;4(20):3515-21.

Samoriski GM, Applegate CD. Repeated generalized seizures induce time-dependent changes in the behavioral seizure response independent of continued seizure induction. J Neurosci. 1997;17(14):5581-90.

Begum MR, Begum A, Quadir E. Loading dose versus standard regime of magnesium sulfate in the management of eclampsia: a randomized trial. J Obstetr Gynaecol Res. 2002;28(3):154-9.

Okusanya BO, Garba KK, Ibrahim HM. The efficacy of 10gram intramuscular loading dose of MgSO. Niger Postgrad Med J. 2012;19(3):143.

Downloads

Published

2022-03-25

Issue

Section

Original Research Articles